Minor
WISPer · MTX-463 · Idiopathic Pulmonary Fibrosis (IPF)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 71 → 59 locations
Mediar TherapeuticsPhase 2 NCT06967805 Registry history of NCT06967805 on ClinicalTrials.gov (opens the registry)